Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abseil Pharmaceuticals is an Indian pharmaceutical company headquartered in West Bengal, specializing in the formulation, manufacturing, and trading of a diverse range of healthcare products. Founded in 2014, the company has established a significant market presence with a portfolio of over 80 products covering therapeutic areas such as cardiology, diabetology, gastroenterology, and mental health. Key products include the ESEIL-PLUS brand for anxiety and stress, as well as various antidiabetic and antihypertensive medications. Abseil operates primarily in the Indian market with a focus on providing affordable, high-quality medicines and is currently expanding its reach both domestically and internationally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abseil Pharmaceuticals.